Wednesday, July 8, 2026

pharma · Infertility · Ovarian Cancer · NWBO

NORTHWEST BIOTHERAPEUTICS

NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorec

4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO · NYSE Ticker
Company details
Status
Public
HQ
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
Founded
1998
Employees
20
Programs
33
Drugs
40
Patents
595
Clinical program

gemcitabine

Phase 3 · small molecule · Non-Small Cell Lung Cancer

gemcitabine for Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

← All NORTHWEST BIOTHERAPEUTICS INC projects Phase 3 small molecule terminated

Internal code CAPPA-2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
NORTHWEST BIOTHERAPEUTICS INC
Phase
Phase 3
Modality
small_molecule
Indication
Non-Small Cell Lung Cancer
Status
terminated
Trials
1